Research Abstract
I am a translational investigator and clinician focused on prostate and testicular cancer as well as phase 1 clinical trials. I focus on epigenomic and genomic mechanisms of drug resistance in cancer with an emphasis on leveraging patient samples to explore disease biology. The goal of these studies is to develop rational molecularly-guided therapeutic strategies to overcome therapeutic resistance.